anxiolytics). Psychiatric and social assessments were made (i) at initial consultation when treatment was started; (ii) one month later; (iii) seven months later. Before treatment the two groups were similar on all main variables. On the General Health Questionnaire, 85 per cent of patients were psychiatric cases before treatment, 40 per cent at one month and 30 per cent at seven months. Similar improvements were found with other measures of psychiatric state (Profile of Mood States; Present State Examination) and social functioning (SAS-M). Improvements were similar and parallel in the two groups. Neither group of patients increased their consumption of alcohol, tobacco or non-prescribed drugs. The non-drug group did not make increased demands on the doctors' time.
Views are divided on this large scale prescribing of psychotropic medication. Some writers believe such prescribing is justified, others deplore it. Three m@sin arguments are usually put forward to justify the widespread prescribing of psychotropic drugs in gen eral practice. The first and commonest argument is that general practitioners usually lack the time to provide counselling as an alternative treatment (Ed wards, 1974) . The second argument is that some widely used drugs, notably benzodiazepines, are safer than alcohol or other drugs which patients might obtain for themselves (Lancet, 1978) . Thirdly, it is argued that drugs such as benzodiazepines are safer than many other drugs when taken in overdosage.
Considerable doubts have been expressed about the value of certain psychotropic drugs in general practice, especially the benzodiazepines (Lancet, 1973 (Lancet, , 1978 Trethowan, 1975; Grahame-Smith, 1975; Edwards, 1979) . There are three main arguments against benzo diazepines:-(a) they are not known to be effective for the symptoms seen in general practice, (b) they may be dangerous, (c) they are costly.
The evidence for the effectiveness of benzodiaze pines is mixed. Some writers have reported that they may be valuable in general practice for minor affective disorders (Wheatley, 1972; Priest, 1980) . On the other hand, studies of psychiatric out-patients and in patients have suggested that a placebo may be as It is established that minor affective disorders are common amongst patients consulting general practi tioners (Goldberg and Blackwell, 1970; Goldberg eta!, 1976) . These disorders present mainly with symptoms of anxiety or depressed mood and often a mixture of the two (Goldberg and Huxley, 1980; Shepherd et a!, 1981) . In many cases social problems appear to have been important in aetiology (Kedward, 1969; Cooper, 1972; Cooper and Sylph, 1973) . Such disorders usually improve within six to twelve months (Kedward, 1969; Goldberg and Blackwell, 1970; Mann eta!, 1981) .
General practitioners commonly prescribe psycho tropic drugs for these minor affective disorders. During the 1960s, there was a steep increase in general practice prescriptions for these drugs, particularly the minor tranquillisers, non-barbiturates and anti depressants (Trethowan, 1975) . During the 1970s such prescriptions continued to increase, but more slowly (Williams, 1980) . In a recent survey of five group general practices in Oxford, Skegg et a! (1977) found that psychotropic drugs were the type of drugs most frequently prescribed in general practice. Amongst registered patients, in the course of one year more than 20 per cent of women and about 10 per cent of men received at least one prescription for a psychotropic drug. Amongst women aged 45, more than 30 per cent received at least one prescription for psychotropic medication in the course of a year.
effective as anxiolytic medication, especially for patients with moderate or low levels of anxiety (Rickels and Downing, 1967; Dasberg and van Praag, 1974; Johnstone et a!, 1980) . There is little evidence that long-term use of benzodiazepines is effective for insomnia or anxiety (Committee on the Review of Medicines, 1980) . Several possible dangers of benzodiazepines have been reported, including:-increased proneness to road traffic accidents (Betts et a!, 1972; Seppala eta!, 1976; Skegg et a!, 1979) ; physical dependence and with drawal reactions (Covi eta!, 1973; Winokur eta!, 1980; Petursson and Lader, 1981) ; hostility and paradoxical reactions (Gardos et a!, 1968; Hall and Joffe, 1972;  Salzman et a! , 1974; British Medical Journal, 1975; Goldney, 1977) ; interaction with alcohol (Hayes et ci, 1977) ; contribution to self-poisoning (Hawton and Blackstock, 1976) . With regard to cost, Trethowan (1975) drew attention to the substantial cost to the Health Service, whilst Leach and White (1978) pointed out that prescribed psychotropic drugs were often wasted.
Apart from these three arguments, it has been reported that the prescribing of psychotropic drugs is often incorrect pharmacologically (Tyrer, 1978) . It is also argued that it can be illogical (and possibly unethical) to prescribe drugs for emotional disorders that appear to be largely caused by social factors.
For all these reasons, it is important to ask whether it would be helpful or harmful to try to reduce the prescribing of psychotropic drugs in general practice. There is evidence that prescriptions for sedatives can be reduced by advertisements directed to doctors and patients (Keeler and McCurdy, 1975) , but the effect of this reduction on patients is not known. In one general practice it has been reported that barbiturate hypnotics could be withheld from patients and the prescribing of all hypnotic medication reduced by half, without causing any apparent harm to patients (Wells, 1973) .
Apart from these two reports, little is known about the effects of withholding psychotropic medication from patients with minor affective disorders. This paper reports a study of the effects of reducing the prescribing of anxiolytic medication in two group practices.
The main aim was to study the effects of withholding anxiolytic drugs from patients to whom the general practitioner would usually prescribe them. at initial consultation ; (iv) unreasonable increases in demands on general practitioners' time. These ques tions are dealt with in this paper.
The design of the study also enabled us to examine a separate question:-in patients to whom anxiolytics are usually prescribed in general practice what factors are associated with a poor outcome in terms of psychiatric status or long-term prescribing? This question is dealt with in paper II.
Method
The study was designed as a prospective trial in which patients were allocated randomly to one of two treatments:
(i) anxiolytic medication; or (ii) brief counselling without anxiolytic medication. Psychiatric and social assessments of the patients were made on three occasions:-(i) at the initial consultation with the general practitioner, when treatment was started; (ii) one month after the initial consultation;
(iii) seven months after the initial consultation.
Selection of patients: In the course of their normal work, the general practitioners identified all those patients to whom they would normally prescribe anxiolytic medication at the time of presentation. Within this group, patients were eligible for the trial if they fulfilled two conditions:â€" (i) They were presenting with a new episode of psychiatric disorder. For this condition â€oe¿ newâ€• meant that the patient had not consulted the general prac titioner for a psychiatric disorder during the preceding three months. (ii) They were not currently taking psychotropic drugs and had not done so during the preceding three months.
Patients were excluded from the trial if (i) they refused treatment; or (ii) the general practitioner judged the psychiatric disorder to be so severe that withholding medication was not justifiable.
Allocation to treatment groups: Patients were ran domly allocated to one of the two treatments as soon as the general practitioner had decided they were suitable for inclusion in the trial, and before he had given any advice, reassurance or other form of treatment. It is emphasised that the general practitioner always de cided whether or not to admit a patient to the trial without knowledge of which treatment would be given. Random allocation was achieved by drawing cards sequentially from a random pack (unknown to the patient).
The two treatment groups (a) Anxiolytic medication: This group will be referred to as the â€˜¿ drug group'. The general prac titioner prescribed anxiolytic medication of his choice for up to two weeks. Thereafter the doctor was free to prescribe further anxiolytic medication as long as it was (1 of patients)+ (all patients)Lifeeventsâ€"â€"+ judged necessary. For the purpose of the investigation, the general practitioners agreed that anxiolytic medi cation would consist of minor tranquillisers, such as diazepam or chlordiazepoxide, to be taken for their calming effect by day, or as hypnotics at night. In this treatment group the general practitioner gave such reassurance and advice as he would usually give when prescribing anxiolytic medication.
(b) Brief counselling without anxiolytic medication: This group will be referred to as â€˜¿ the non-drug group'. The general practitioner was to give brief counselling without attempting any specialized counselling or psychotherapy.
It was stipulated that this brief coun selling could include:-explanation of the nature of any symptoms and why they had occurred; exploration of underlying personal or other problems, and ways of dealing with them; and reasons for not prescribing drugs (if appropriate).
The general practitioners were given guidance and written information about the use of these techniques during the pilot stage of the investigation.
In both treatments, the general practitioners carried out any necessary physical examinations.
Methods of assessment: At the end of the initial consultation, the general practitioner explained to the patient that an investigation was being made into emotional problems and methods of treatment. The general practitioner then invited the patient to take part in the assessment procedures described below. The assessment procedures and their timing are shown in Table I . As already explained, assessments were made on three occasions:-at the initial consultation; one month later; and seven months after the initial consultation. The information collected was of three main kinds:-self-ratings by the patients; observations recorded by the general practitioners; observations made by three interviewers from the research team.
TABLE I
Patients' self-ratings: At all three stages of assessment, the patients completed the following self-ratings:â€" (a) Mental state measured by the General Health Questionnaire, or GHQ (Goldberg, 1972; Goldberg and Hillier, 1979) , and by the Proffle of Mood States, or POMS (McNair and Lorr, 1964) . The questionnaires were handed to patients by the general practitioner at the end of the initial consulta tion and were returned to the research team by post. At the two follow-up assessments, the questionnaires were sent out and returned by post.
Observations by general practitioners: At the initial interview, the general practitioners used standard forms to record the following:-the nature, severity and duration of the psychiatric problem; any physical disorder; any social problems; all medication pre scribed at the initial consultation, and any other help given; the duration of the initial consultation. At the end of the study, members of the research team examined the practice records of all patients in the study, and abstracted information on GP-patient contacts and any prescription of psychotropic medica tion during the seven month follow-up.
Observations by research assistants: It was thought important to avoid as far as possible any therapeutic effects that might occur through extended contact groups were comparable in demographic charactens tics, and also in the general practitioners' assessments of their presenting complaints, social difficulties, and associated physical disorders (see below). As shown in Table III , at the initial assessment there were only minor differences between the two treatment groups in the standardized measures of mental state. The same also held for the measures of social functioning (not shown in Table III ). Both of these sets of measures are described in detail later.
The characteristics of the two samples are given in Table II ; the social class distribution of the patients did not differ significantly from the general population. As shown in Table II , the general practitioners' findings were much the same for the two treatment groups. According to the GPs the main presenting complaint was tension; other common complaints were palpita tions, breathing difficulties, headaches, depressed mood, and insomnia. Over half of these complaints had started less than a month previously. Concurrent social difficulties in family, marriage or work were each reported by over a third of the patients. Concurrent medical conditions were diag nosed by the general practitioner in about a third of the patients. Most of these conditions were minor physical ailments or chronic disorders.
Treatment given 1. At initial consultation:
(a) Duration of consultation: According to records kept by the general practitioners, the durations of initial consultations were: drug group 3â€"20 minutes (mean 10.5; SD 4.2); non-drug group 3â€"25minutes (mean 12; SD 4.7); the difference is not significant. -(b) Psychotropic medication: At the initial consulta tion the non-drug group received no psychotropic medication.
In the drug-group, the numbers of patients receiving anxiolytic drugs were:-diazepam by day, 33 (78 per cent); chlordiazepoxide by day, 5 (12 per cent); nitrazepam at night, 2 (5 per cent). In addition, two (5 per cent) patients received minor tranquillisers combined with an antidepressant, pre scribed specifically for their anxiolytic effects. All drugs were prescribed in the dose recommended in the National Formulary. All initial prescriptions were for two weeks' supply.
(c) Non-psychotropic drugs: These were prescribed to nine patients (21 per cent) in the drug group, and 16 patients (32 per cent) in the non-drug group (differ ence not significant).
The drugs prescribed most commonly were analgesics and preparations acting on the alimentary and cardiovascular systems. (d) Counselling by the general practitioners: Ac cording to the practitioners, advice on coping with difficulties was given to more patients in the non-drug between patients and research assistants. For two thirds of the patients, therefore, during the initial and the one-month assessments, the research assistants made contact only to give out or collect self-admims tered questionnaires.
For a randomly selected one third of patients, contact at these two assessments included an interview using the Present State Exami nation, or PSE (Wing et a!, 1974) . On completion of the study at seven months, all patients in the trial were assessed with the PSE. The PSE was used to provide an outcome measure and to check the findings with the self-administered questionnaires (GHQ and POMS). At the final follow-up, the research assistants also administered an inventory of life events (Paykel et a!, 1969), covering the six months before the interview. Most interviews were held in the patients' homes but a few were held (at the patient's request) in the health centre. Interviews were carried out by a research psychiatrist (JC) and two research assistants (AB and GE), all of whom had extensive experience in psychiatric interviewing and particularly the use of the
PSE.
The practices: Patients were selected from those attending two health centres sited in towns within a few miles of Oxford City. Patients were admitted to the study over a period of twelve months in one health centre, and four months in the other. Six general practitioners participated, three from each health centre.
Results
Requests were made to 124 patients to enter the study of whom 33 (27 per cent) were excluded because they were unwilling to complete the questionnaires. These excluded patients did not differ from the remaining patients in their sex, age and presenting complaints as rated by the general practitioners. On entering the study, all 91 patients completed the first set of questionnaires and 31(34 per cent) of them were interviewed by the research assistants (this was in accordance with the research plan outlined above). At the one-month follow-up, two of the 91 patients declined to participate (one of whom was from the previously interviewed group). At the seven-month follow-up, two patients declined to participate, whilst a further three completed questionnaires but declined to be interviewed.
At this final follow-up, therefore, questionnaire data were available from 87 (96 per cent), and interview data from 84 (92 per cent) of the initial sample.
Of the patients admitted at the initial consultation, 42 (46 per cent) were allocated to the drug-group, and 49 (54 per cent) to the non-drug group. At the first assessment, the two treatment groups were compara ble on virtually all measures. As shown in Table II ( 2) 24 (57) 10 (24) 7 (17) 6 (14) 6 (14) 4 (10) 6 (14) 18 (43) 12 (29) 3 ( 7) 3 ( 7) 18 (43) 14 (34) 17 (40) 2 ( 5) 15 (36) 9 (18) 37 (75) 3 ( 6) 1 ( 2) 13 (27) 21 (43) 12 (24) 1 ( 2) 1 (2) 21 (43) (x2 =6.78; df=1;P<0.01). Nosignificant differences were found in the frequency, as reported by the practitioners, of the following:-listening to the patients (98 per cent in both groups); explaining symptoms (50 per cent in the non-drug group, and 67 per cent in the drug-group); reassurance (33 per cent in the non-drug group, and 35 per cent in the drug group). It is interesting that the patients generally perceived their doctors' actions in the same way. Thus, according to the patients, the frequencies were: advice on coping with difficultiesâ€"non-drug group 41 per cent, drug group 17 per cent (x2 = 4.44; df = 1; P <0.05); listening to the patientâ€"drug-group 96 per cent, non-drug group 93 per cent; explaining cause of symptomsâ€"drug group 41 per cent, non-drug group 51 percent.
One-month follow-up
In the drug group, 19 patients (46 per cent) were still taking anxiolytic medication; of the 22 patients (54 per cent) who were not doing so, three (7 per cent) never 16.0( 6.4)6.7 ( 6.1) 6.1 ( 6.0) 13.1( 3.6) 13.5( 3.7)6.0 ( 5.6) 4.3 ( 3.4) 11.4( 4.1) 11.5( 3.9)Lower scores indicate less severity
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took the prescribed medication (one losing the pre scription, two recovering rapidly before using it), nine (22 per cent) stopped taking the prescribed drug within one week and 10(24 per cent) within one to two weeks. In the non-drug group, one patient returned to the practitioner a week after the initial consultation and was given a prescription for a hypnotic.
Seven-month follow-up
In the drug group, information was available on 40 patients. Of these, 13 (32 per cent) had received at least one prescription for psychotropic drugs in the six months since the one month follow-up.
These patients included five who had received a single prescription and eight who had received two to six prescriptions; nine of these patients were given anxiolytics, and four antidepressants.
In the non-drug group, information was available on 47 patients. Of these, seven (15 per cent) had received at least one prescription; they included four patients who had received one prescrip tion for psychotropic medication and three who had received two to four such prescriptions. Three of these had received antidepressants. There was thus a trend for the non-drug group to receive fewer prescriptions but the difference was not significant.
Further contacts with the general practitioner
Between the initial interview and the seven-month follow-up, the mean numbers of further contacts with the practitioner were:-drug-group, 4.6; non-drug group, 4.5 (N.S.). According to the practitioners' records, psychological symptoms were mentioned in significantly more re-visits by the drug-group (55 per cent) than by the non-drug group (35 per cent; x2 = 15.4; df = 1; P <0.001).
Consumption of other substances
According to the patients' reports, during the study period there were no increases in the numbers of patients consuming alcohol or tobacco, or in the amounts consumed by individual patients. No differ ences were found between the two treatment groups in the use of these substances. Similarly, there was no significant change in consumption of non-prescribed drugs over time or by treatment group.
Psychiatric status
The information given in the following section is summarised in Table III .
General Health Questionnaire (GHQ)
(a) GHQ cases: There were no significant differ ences between the drug-group and the non-drug group
TABLE III

Psychiatric status by treatment group at initial consultation and both follow-ups
5PSE results apply to a subsample at initial assessment (N = 31) and one-month follow-up (N = 30), and 84 patients at the seven month follow-up.
on any GHQ measure at any stage of the enquiry. Patients were classed as psychiatric cases if they had a total score of 12 or more on the GHQ (60 item version). On this definition, at the initial consultation, there were 36 cases (86 per cent) in the drug group and 39(80 per cent) in the non-drug group. At the one-month follow-up, the numbers of cases had fallen to 16(38 per cent) in the drug-group, and 22 (46 per cent) in the non-drug group. Both reductions were significant at the 0.001 level.
At the seven-month follow-up, the numbers of cases were again smaller, 12(28 per cent) in the drug-group, and 12(26 per cent) in the non-drug group; again these proportions were lower than those at initial consulta tion at the one in a thousand level of significance. The proportions of cases by treatment groups at the three stages of assessment are shown in Figure 1 . (b) GHQ mean total score: The above findings for GHQ cases were reflected in the mean total scores of the two treatment groups. At the initial consultation, the means were: drug group 26.4 (sd 13.8), non-drug group 24.2 (sd 13.5). At one-month follow-up the means were: drug group 11.3 (sd 10.1), non-drug group 13.7 (sd 11.2); and at seven month follow-up: drug group 7.6 (sd 10.8), non-drug group 7.2 (sd 12.5). Compared with the initial consultation, the mean total scores were significantly reduced at both follow-ups (P <0.001).
(c) GHQ sub-scores: The main finding was that, at all three stages of assessment, sub-scores for anxiety and for somatic symptoms were considerably higher than for depression.
GHQ sub-scores showed im provements at the one-month and seven months follow-ups, with no significant difference between treatment groups. Taken together, the GHQ findings suggest that the general practitioners had initially identified a group of patients who had high levels of psychiatric morbidity, which mainly took the form of anxiety.
Profile ofmood states (POMS)
(a) Total score: There was no significant difference between the two treatment groups at any stage of assessment. Compared with initial consultation, there were significant reductions (improvement) in the POMS total score both at the one-month follow-up (P <0.001 for both treatment groups), and at the seven-month follow-up (P <0.001 for both treatment groups).
(b) Sub-scores: At the initial consultation, the drug group had a higher mean score than the non-drug group on one of the five sub-scores,â€"anger (t = 2.09, P <0.05). At the one-month follow-up, both treatment groups showed significant improvements in three of the sub-scores,â€"tension, depression and fatigue (P <0.001). Only the drug-group showed a significant improvement in â€˜¿ anger' (P <0.001) but analysis of covariance showed no significant difference between the two treatment groups in this respect (t = 1.20, NS). Analysis of covariance showed that the non-drug group had improved significantly more in â€˜¿ vigour' (t = 4.03; P <0.01). At the seven-month follow-up, all the POMS sub-scores showed significant reductions when compared with the initial consultation; there were no significant differences between the two treatment groups.
Present state examination (PSE)
Patients were counted as PSE cases if they were at levelS or higher on the PSE Index of Definition (Wing eta!, 1974) . At the initial consultation, interviews were held with 15 patients in the drug-group and 16 in the non-drug group. The numbers of PSE cases were 12 (80 per cent) and 12 (75 per cent) respectively. At the one-month follow-up, 15 patients from each treatment group were interviewed. The numbers of PSE cases were six (43 per cent) in the drug-group and seven (44 per cent) in the non-drug group. At the seven-month follow-up, 84 patients were interviewed. The numbers of PSE cases were 11(29 per cent) in the drug group, and 15 (33 per cent) in the non-drug group. Twenty eight patients were assessed with the PSE at all three assessments. Analysis of the change scores showed significant reductions at one month (drug group, P <0.05; non-drug group, P <0.001) and at seven months (drug group, P <0.001; non-drug group, P <0.001). Analysis of covariance showed no signifi cant difference between the two treatment groups in this respect. 
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Patients' ratings of changes in presenting complaints at the two follow-up assessments
Relationships between GHQ and PSE findings
Highly significant correlations (Pearson) were found between PSE total scores and GHQ total scores at the intial consultation (P <0.001), at the one-month follow-up (P <0.001) and at the seven-month follow up (P <0.001). On comparison of psychiatric cases v.
non-cases identified by the PSE Index of Definition and those identified by the GHQ, agreement was found to be 80 per cent at initial consultation, 80 per cent at one-month follow-up and 87 per cent at seven month follow-up.
Patients' self-assessment of psychiatric status
The patients' ratings of changes in their presenting problems are shown in Table LV . It can be seen that over three quarters of the patients rated themselves as better or recovered at both follow-ups. There were no significant differences between treatment groups.
Deliberate self-harm
No patients deliberately took overdoses or injured themselves during the study period.
Social adjustment
(a) SAS-M total score: Compared with the initial assessment, there were significant improvements in SAS-M total scores both at the one-month follow-up (drug-group, P <0.01; non-drug group, P <0.01) and at the seven-month follow-up (drug group, P <0.001; non-drug group, P <0.01). There were no significant differences between the two treatment groups in degree of improvement at either follow-up.
(b) SAS-M sub-scores: The SAS-M includes the sub scores: work, housework, social and leisure, extended family, marriage, children, and family unit. At both the one-month and the seven-month follow-ups, the two treatment groups showed significant improve ments on most of the sub-scores. At the seven-month follow-up, analysis of covariance showed significant differences between the two treatment groups in just one sub-score,-â€"socialand leisure (t = 7.44, P <0.01), in favour of the drug group.
Patients' expectations and satisfaction
(a) Satisfaction with duration of initial consultation:
Of the 91 patients entering the study, only five (four drug-group and one non-drug group) expressed dissat isfaction with the duration of the initial consultation.
(b) Expectations of receiving drugs: Of the 91 patients, 47 (52 per cent) said they expected to receive a prescription for psychotropic drugs. There were no significant differences between the two treatment groups in these expectations. Thirteen patients in the drug-group (31 per cent) and 11 in the non-drug group (22 per cent) said they had asked the practitioner to prescribe drugs for their â€˜¿ nerves'.
(c) Patients' satisfaction with prescribing/non-pre scribing: The patients' satisfaction with the prescrib ing/non-prescribing of psychotropic drugs is shown in Table V . There were no significant differences between the two treatment groups at any stage, although the non-drug group tended to give more extreme responses. At the seven-month follow-up patients were asked whether they thought the prac titioner might have done anything else to help. Affirmative responses were given by 19 patients in the drug-group (66 per cent) as against 15 in the non-drug group (37 per cent; x2 = 3.92; df = 1, P <0.05).
Amongst these patients giving affirmative responses, most would have welcomed referral to a psychiatrist or marriage guidance counsellor.
Discussion
Before discussing the findings, it is important to consider the sample of patients and the treatments they received.
Initial interviewOne monthSevenmonthsDrug
groupNon-drug groupDruggroupNon-drug groupDruggroupNon-drug groupN(%)N(%)N(%)N(%)N(%)N(%)Glad15 ( 36)22 ( 45)14 ( 34)21 ( 44)19 ( 47) ( 33)14 ( 34)19 ( 40)11 ( 28)12 ( 26)Reluctant13 (30)6 (12)11 (27)7 (14)10 (25)10 (21)Againstâ€"5(10)2(5)1(2)â€"â€"42(100)49 (100)41 (100)48(100 The first point to stress about the sample is that patients were selected by the general practitioners and not by the research team. The general practitioners were asked to select all those patients to whom they would normally prescribe anxiolytic medication. It was hoped that this method of selection would make the investigation more realistic. The only limitations were that the patients must be presentingwith a new episode of psychiatric disorder and must have taken no psycho tropic medication in the preceding three months.
According to the general practitioners, the patients' initial complaints were mainly of tension, bodily symptoms typical ofanxiety, and insomnia. About half the patients had experienced their symptoms for less than a month and 85 per cent for less than three months, during the present episode of illness. General Health Questionnaires completed at the initial inter view showed that over 80 per cent of the patients were psychiatric cases. The sub-scores of the GHQ showed that symptoms of anxiety and somatic symptoms were more common than depressive symptoms. These findings suggested that the general practitioners had identified a group of patients with substantial psychia tric morbidity, mainly in the form of anxiety.
Two thirds of the patients were women. For patients of both sexes the mean age was in the early thirties and their social class was typical of the background population. Of the 91 patients initially admitted to the study, 42 (46 per cent) were allocated to the drug treatment group, and 49 (54 per cent) to the non-drug group. These two treatment groups were comparable in their demographic characteristics, presenting com plaints, assessments by the general practitioners, and scores on all standardized measures of mental state (GHQ; POMS; PSE) and of social functioning (SAS M).
The medication given to the drug-group seemed typical of general practice prescribing for minor affective disorders. The drugs prescribed were diazepam, chlordiazepoxide, nitrazepam, and anti depressant combined with minor tranquillisers. Most of these drugs were taken for a short period, although at the one-month follow-up, 19 of the original 42 patients were still on psychotropic medication. At the 7-month follow-up, the figure was 13.
As judged by the general practitioner's reports of the content and duration of the initial interview, the treatment given to the non-drug group was certainly not intensive or specialised. The main treatment was advice, which was given to two thirds of the non-drug group (as against one third of the drug group). Other techniques included listening, explanation and reas surance , but these were given to the non-drug group no more frequently than to the drug group. After the initial interview there was some prescribing of medica tion to the non-drug group; by the one-month follow up, one non-drug patient had received a prescription, and by the seven-month follow-up seven non-drug patients had done so.
Turning now to the findings, the purpose of the study was to answer four questions, which will be considered in turn. The first question was: Does withholding anxiolytic drugs prolong psychological distress that might have been relieved by anxiolytic medication? All the findings pointed to a negative answer to ths question. Thus in the drug group the proportions of psychiatric cases on GHQ were: 86 per cent initially, 38 per cent at one month, and 28 per cent at seven months. For the non-drug group, the corresponding proportions were:â€" 80 per cent, 46 per cent and 26 per cent. For both treatment groups, there were significant improvements at one month and at seven months compared with their initial status. There were no significant differences between the two groups at any stage of assessment.
Similarly, when the POMS and PSE were used to measure psychiatric status, no significant differences were found between the drug group and the non-drug group at any stage of assessment. Again there were significant improvements at one month and at seven months, by comparison with the initial interview. The same observations held for social adjustment as measured by the SAS-M,â€"there were significant improvements at both follow-ups, and no significant differences between the two treatment groups. Finally, at both follow-ups over three quarters of the patients rated themselves as better or improved, and there were no significant differences between the treatment groups. Taken together, these findings point strongly to the conclusion that the prescribing of anxiolytic drugs made no significant difference to the psychiatric or social outcome. pointed to a negative answer. There were no reported increases in the use of alcohol, tobacco, or non prescribed drugs. This was true both for the numbers of patients using the substances and for the amounts consumed by individuals. Nor was there any difference between treatment groups in these measures. It is of course possible that the patients' self-reports were not always dependable but the available evidence does not point to any increase in consumption of these substances.
The third question was: Does withholding anxiolytic medication fail to fulfil the, patients' expectations?
Several questions were asked about this possibility, and all the responses pointed to a negative answer. For example, when patients were asked to rate their satisfaction with the prescribing/non-prescribing of drugs, no significant difference was found between the two treatment groups.
The final question was: Does withholding anxiolytic medication make unreasonable demands on the general practitioners' time? Once again the answer appeared to be in the negative. The mean duration of the initial interview was 10.5 minutes for the drug group, and 12 minutes for the non-drug group. During the entire follow-up period, the mean rate of further consulta tions with the practitioner after the initial consultation was 4.6 consultations for the drug group, and 4.5 for the non-drug group.
In this particular sample of patients, therefore, all the findings suggested that witholding anxiolytic drugs did not have harmfuleffects. An important question is:
How far can the findings be generalised to other patients, and to other GPs? In their demographic and psychiatric characteristics, the patients seemed similar to patients with â€˜¿ new episodes of psychiatric disorder described in other general practice studies (Cooper and Sylph, 1973; Shepherd et a!, 1981) . The general practitioners were perhaps unusual in their willingness to participate in the study, but they were typical in havingno specialised experience ortraining inpsycho logical methods of treatment. It therefore seems reasonable to suppose that the findings of the study may be widely applicable to patients and general practitioners in the United Kingdom. Two main conclusions can be drawn from this part of the study. The first is that anxiolytic medication can be withheld without causing harmful effects to patients who have minor affective disorders and somatic complaints of recent onset, as diagnosed by the GP, and confirmed by standardized tests of mental state. If no medication is prescribed to them, such patients seem to recover as quickly and as much as patients who receive anxiolytic medication. The second conclusion is that managing patients without anxiolytic medica tion does not make unreasonable demands on the doctors' time. For most patients, the only require ments are brief discussion of their symptoms, explana tion of family and social difficulties, and advice on dealing with problems. In some cases referral to other agencies, such as marriage guidance or social services, may be suitable.
Although patients allotted to the non-drug group were no more disturbed than patients allotted to the drug group at the one month follow-up, we do not know whether this was so in the days immediately following the initial consultation. It is possible that the main indication for anxiolytics is to tide the patient over these first few days by reducing acute distress. Whilst most of the patients in the trial recovered from the initial disorder, about one third were still unwell at the seven-month follow-up. Moreover, as many as 20 (24 per cent) patients received prescriptions for psychotropic medication between the one-month and seven-month follow-up. It is important to examine the characteristics of these patients, and to discover what factors were associated with a poor outcome. These issues are taken up in the next paper.
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